Neuron-Specific Enolase (NSE): Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
| Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 49: | Line 49: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Blood tests]] | [[Category:Blood tests]] | ||
Revision as of 14:17, 20 August 2012
| Neuron-Specific Enolase (NSE) |
Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Neuron-specific enolase is a tumor marker that can indicate small cell lung cancer.
| Reference Range |
| <10 micrograms/ liter |
Differential Diagnosis
In alphabetical order. [1] [2]
Increased
- Breast Cancer
- Bronchopneumonia
- Carcinoid
- Hemolysis
- Kidney Cancer
- Liver Disease
- Medullary thyroid cancer
- Melanoma
- Neuroblastoma
- Pancreatic endocrine tumors
- Pulmonary fibrosis
- Seminoma
- Small cell lung cancer